AFT Pharmaceuticals Ltd. ASX: AFP Share Price & Review

AFP Overview

AFP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Weak

Halo Model

MQV

Strong

GARP

Neutral

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Neutral

About AFP

Website

N/A

Telephone

64.800.423.823

Address

Level 1 129 Hurstmere Road, Takapuna Nielsen House Auckland 0622

Description

AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World. The Australia segment caters to the Australian market. The New Zealand segment focuses on the head office function, supplier relationships and procurement of stock, and regulatory, marketing, and finance activities of the group. The Asia segment relates in the sales activities in Brunei, Hong Kong, Malaysia, Philippines, Singapore, and Vietnam markets. The Rest of the World segment consists of out licensing of internet protocol developments to markets in which the firm does not have a presence and the export of products to export markets. The company was founded by Hartley Atkinson and Marree Atkinson on September 4, 1997 and is headquartered in Auckland, New Zealand.

AFP Price Chart

Key Stats

Market Cap

AU$258.83M

27.80

EV/EBITDA

0.0

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

18-Jun-25

Market Data

52 weeks range

Low 2.15 - 3.16

Trade Value (12mth)

AU$957.00

1 week

-2.35%

1 month

-0.4%

YTD

-3.49%

1 year

-14.14%

All time high

5.25

Key Fundamentals

EPS 3 yr Growth

-41.90%

EBITDA Margin

9.40%

Operating Cashflow

$10m

Free Cash Flow Return

8.70%

ROIC

9.70%

Interest Coverage

6.90

Quick Ratio

1.40

Other Data

Shares on Issue (Fully Dilluted)

105m

HALO Sector

Healthcare

Next Company Report Date

25-May-26

Ex Dividend Date (est.)

18-Jun-25

Next Dividend Pay Date (est.)

04-Jul-25

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AFP Announcements

Latest Announcements

Date	Announcements
04 July 25	Disclosure of Directors and Senior Managers Relevant Interes × Disclosure of Directors and Senior Managers Relevant Interes
01 July 25	June Quarter FY 2026 Investor Update × June Quarter FY 2026 Investor Update
27 June 25	Disclosure of Directors and Senior Managers Relevant Interes × Disclosure of Directors and Senior Managers Relevant Interes
27 June 25	Notice of Annual Meeting of Shareholders 2025 × Notice of Annual Meeting of Shareholders 2025
24 June 25	Update - Dividend/Distribution - AFP × Update - Dividend/Distribution - AFP
24 June 25	Update - Dividend/Distribution - AFP × Update - Dividend/Distribution - AFP
26 May 25	AFT and Hikma extend US Maxigesic Cooperation × AFT and Hikma extend US Maxigesic Cooperation
23 May 25	Dividend/Distribution - AFP × Dividend/Distribution - AFP
22 May 25	FY2025 Presentation × FY2025 Presentation
22 May 25	FY2025 App2 × FY2025 App2
22 May 25	FY2025 Market Release × FY2025 Market Release
22 May 25	FY2025 Annual Report × FY2025 Annual Report
22 May 25	FY2025 Distribution notice × FY2025 Distribution notice
22 May 25	FY2025 Distribution Notice correction × FY2025 Distribution Notice correction
01 May 25	AFTto announce full year results on Thursday May 22 2025 × AFTto announce full year results on Thursday May 22 2025
31 March 25	March investor update × March investor update
26 March 25	ASX small cap presentation 250326 × ASX small cap presentation 250326
13 January 25	NEW YEAR LETTER TO INVESTORS × NEW YEAR LETTER TO INVESTORS
02 December 24	Disclosure of Directors and Senior Managers Relevant Interes × Disclosure of Directors and Senior Managers Relevant Interes
27 November 24	Disclosure of Directors and Senior Managers Relevant Interes × Disclosure of Directors and Senior Managers Relevant Interes
27 November 24	Disclosure of Directors and Senior Managers Relevant Interes × Disclosure of Directors and Senior Managers Relevant Interes
21 November 24	FY25 Interim NZX App2 × FY25 Interim NZX App2
21 November 24	FY25 Interim release × FY25 Interim release
21 November 24	FY25 Interim Report × FY25 Interim Report
21 November 24	FY25 Interim Presentation × FY25 Interim Presentation

Dividends

Key Stats

Ex Dividend Date (est.)

18-Jun-25

DIV Yield

.0%

Franking Level

N/A

DPSg

10.50%

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AFP Shortsell

Frequently Asked Questions

What is the current share price of AFT Pharmaceuticals Ltd. (AFP:ASX)?

The current share price of AFT Pharmaceuticals Ltd. (AFP:ASX) is AU$2.49.

What is the 52-week high share price for AFT Pharmaceuticals Ltd. (AFP:ASX)?

The 52-week high share price for AFT Pharmaceuticals Ltd. (AFP:ASX) is AU$3.16.

What is the 52-week low share price for AFT Pharmaceuticals Ltd. (AFP:ASX)?

The 52-week low share price for AFT Pharmaceuticals Ltd. (AFP:ASX)? is AU$2.15.

What is the dividend yield for AFT Pharmaceuticals Ltd. (AFP:ASX)?

The current TTM dividend payout for AFT Pharmaceuticals Ltd. (AFP:ASX) is 0.00.

What was AFT Pharmaceuticals Ltd. (AFP:ASX) last dividend payment?

The last dividend payment of AFT Pharmaceuticals Ltd. (AFP:ASX) is AU$0.02.

What is the franking level for AFT Pharmaceuticals Ltd. (AFP:ASX)?

AFT Pharmaceuticals Ltd. (AFP:ASX) has a franking level of 0.0%.

In which sector is AFT Pharmaceuticals Ltd. (AFP:ASX) classified?

AFT Pharmaceuticals Ltd. (AFP:ASX) is classified in the Healthcare.

What is the price-to-earnings (P/E) ratio for AFT Pharmaceuticals Ltd. (AFP:ASX)?

The current P/E ratio for AFT Pharmaceuticals Ltd. (AFP:ASX) is 27.80.